Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma

Thornton, MJ; Williamson, HV; Westbrook, KE; Greenup, RA; Plichta, JK; Rosenberger, LH; Gupta, AM; Hyslop, T; Hwang, ES; Fayanju, OM

Fayanju, OM (reprint author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.; Fayanju, OM (reprint author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA.; Fayanju, OM (reprint author), Durham VA Med Ctr, Durham, NC 27705 USA.

ANNALS OF SURGICAL ONCOLOGY, 2019; 26 (10): 3166

Abstract

Background Neoadjuvant chemotherapy (NACT) is often recommended for patients with node-positive invasive lobular carcinoma (ILC) despite unclear benef......

Full Text Link